# 119-s-3474: Cannabinoid Safety and Regulation Act

119-s-3474, Cannabinoid Safety and Regulation Act, is a 119th Congress bill sponsored by Sen. Wyden, Ron [D-OR] (D-OR); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-s-3474
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-3474
- Congress: 119
- Title: Cannabinoid Safety and Regulation Act
- Status: introduced
- Introduced: 2025-12-15
- Sponsor: Sen. Wyden, Ron [D-OR] (D-OR)
- Cosponsors: 2
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

This bill would establish **an FDA-led federal regulatory framework for hemp-derived cannabinoid products** that sets testing, labeling, packaging, age limits, facility registration, and enforcement rules. It would also fund research and prevention programs for impaired driving and underage use. - Families and young people: Sets a 21+ sales limit for remote purchases, requires reliable age verification, and bans packaging designed to appeal to children. - Consumers and pet owners: Requires clear labels showing total THC and other cannabinoids per serving, species warnings for animal products, accredited lab testing, safety thresholds, and terpene limits (added terpenes ≤5%, natural terpenes ≤6%). - Manufacturers, labs, and states: Requires facility registration, current good manufacturing practices, ISO 17025 or equivalent lab accreditation, product listing, and exposes violators to civil fines up to $15,000 per violation and up to $15 million per proceeding. *This bill would increase federal spending by authorizing $30 million per year for 2026–2030 for impaired-driving research and education and $25 million per year for 2026–2030 for underage-use prevention grants.*

## Cosponsors (2)

- Sen. Merkley, Jeff [D-OR] (D-OR), 2025-12-15T00:00:00.000Z
- Sen. Smith, Tina [D-MN] (D-MN), 2026-01-13T00:00:00.000Z

## Provisions PRIA read

- New national safety and label rules: benefit, high. This bill would require the Secretary to set national product safety and label rules within one year. In States without serving-size laws, THC would be capped at 5 mg per serving and 50 mg per container for edibles, inhalables, and topicals, and 10 mg per container for drinkable products. Labels wo…
- Safer packaging, flavors, and age checks: benefit, high. This bill would ban many added flavors in electronic vaping products and limit terpene levels to 5–6% of product weight. It would bar products and packaging that imitate candy or appeal to children, and require gummy products to be simple geometric shapes. Remote sellers of THC-containing products…
- More funding for cannabis health research: benefit, high. This bill would raise baseline public-health surveillance funding to $596 million per year for FY2026–2030. It would add $100 million per year for cannabis adverse-effect surveillance for the same years. The bill would also fund grants to prevent underage cannabis use, providing $25 million per yea…
- Funding to reduce cannabis-impaired driving: benefit, medium. This bill would direct DOT and NHTSA to develop best practices, national campaigns, and a National Roadside Survey to reduce cannabis-impaired driving. States could get grant money for enforcement, toxicology lab capacity, and education. Congress would appropriate $40 million per year for the State…
- New facility registration, fees, and suspensions: cost, medium. This bill would require companies that make, package, import, label, or hold cannabinoid products to register each facility and list products. Existing facilities would register within 90 days and new facilities within 30 days of starting covered activities. The Secretary could charge a registratio…
- Stricter manufacturing and lab rules: mixed, high. This bill would require good manufacturing practice rules within nine months and testing regulations within 18 months. Labs that test cannabinoid products would need state certification or accreditation and ISO 17025-level proof, and must use validated, published methods for potency and contaminant…

## Related bills

- 119-s-891: Bipartisan Health Care Act
- 119-s-5071: Children's Safe Welcome Act of 2026
- 119-s-5022: Cannabis Administration and Opportunity Act
- 119-s-2819: Head Start for America's Children Act
- 119-s-3990: PrEP Access and Coverage Act of 2026
- 119-s-2823: FAMILY Act

## Sources
- [119-s-3474 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/3474)

## Related
- [119-s-891: Bipartisan Health Care Act](https://policyrisk.com/legislation/119-s-891)
- [119-s-5071: Children's Safe Welcome Act of 2026](https://policyrisk.com/legislation/119-s-5071)
- [119-s-5022: Cannabis Administration and Opportunity Act](https://policyrisk.com/legislation/119-s-5022)
- [119-s-2819: Head Start for America's Children Act](https://policyrisk.com/legislation/119-s-2819)
- [119-s-3990: PrEP Access and Coverage Act of 2026](https://policyrisk.com/legislation/119-s-3990)
- [119-s-2823: FAMILY Act](https://policyrisk.com/legislation/119-s-2823)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-3474 (as of 2026-04-21).